The American Journal of Managed Care October 2006
Outpatient Medication Use and Health Outcomes in Post-Acute Coronary Syndrome Patients
The authors wish to thank Manfred Strommel, PhD, for his contribution to the manuscript. We are also grateful to the 2 anonymous reviewers for their comments to improve this article. The authors take responsibility for any errors occurring in the manuscript.
Our study sheds light on the association between medication use and health outcomes among ACS patients, showing the combined effect of discharge prescriptions and subsequent use of medications in outpatient clinical settings. The effort made by the outpatient physicians could be as important as that of the inpatient care physicians who write discharge prescriptions in promoting the use of outpatient medications shown previously to be effective for ACS patients. Further research on quality improvement interventions for chronically ill patients should focus on the outpatient care provided after acute inpatient events.
From the Department of Health Services Research, Management and Policy, University of Florida, Gainesville, Fla (ZY); and the Department of Medicine (AO, DR), the College of Nursing (WC), and the Center for Ethics and the Department of Medicine (MHR), Michigan State University, East Lansing, Mich.
This project was funded in part by the Agency for Healthcare Research & Quality grants R01 HS10531 and R01 HS09514-S1.
Address correspondence to: Zhou Yang, PhD, MPH, Department of Health Services Research, Management and Policy, University of Florida, 101 S Newell Dr, Rm 4141, Gainesville, FL 32610-0195. E-mail: firstname.lastname@example.org.
1. Braunwald E, Antman EM, Beasle JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2002;16:1893-1900.
2. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-2372.
3. Eagle KA, Klinge-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73-81.
4. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
5. Frilling B, Schiele R, Gitt A, et al. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: results from the MITRA study. Am Heart J. 2004;148:306-311.
6. McCormick D, Curwitz JH, Darleen L, et al. Use of aspirin, beta-blockers, and lipid-lowering medication before recurrent acute myocardial infarction. Arch Intern Med. 1999;159:561-567.
7. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
8. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of b-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
9. Lappe JM, Muhlestein JB, Lappe DL, et al. Improvement in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med. 2004;141:446-453.
10. Muhlestein JB, Horne BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol. 2001;87:257-261.
11. Bradley EH, Herrin J, Mattera JA, et al. Quality improvement efforts and hospital performance: rates of beta blocker prescription after acute myocardial infarction. Med Care. 2005;43:282-292.
12. Bradley EH, Herrin J, Mattera JA, et al. Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Med Care. 2004;42:591-599.
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
14. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
15. Frasure-Smith N, Lesperance F. Gender, depression and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26-37.
16. Hlatky MA, Boineau RE, Higginbotham MB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651-654.
17. Kaul P, Armstrong PW, Fu Y, et al. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy. Can J Cardiol. 2004;20:760-766.
18. Koch CG, Khandwala F, Cywinski JB, et al. Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg. 2004;128:284-295.
19. Rankin SH. Women recovering after acute myocardial infarction: psychological and physical functioning outcomes for 12 months after acute myocardial infarction. Heart Lung. 2002;31:399-410.
20. Olson MB, Kelsy SF, Matthews K, et al. Symptoms, myocardial ischemia, and quality of life in women: results from the NHLBI-sponsored WISE study. Eur Heart J. 2003;23:1506-1514.
21. Hillers TK, Davis D, Frech F, et al. Quality of life after myocardial infarction. J Clin Epidemiol. 1994;47:1287-1296.
22. Reiffel JA. Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clin Cardiol. 2005;28:I28-I37.
23. Esep JD, Mehta SK, Uddin F, et al. Beta-blocker therapy in patients with heart failure in the urban setter: moving beyond clinical trials. Am Heart J. 2005;148:958-963.
24. Witham MD, Gillespie ND, Struthers AD. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. Age Ageing. 2004;33:467-472. Epub 2004 June 24.
25. Hlatcky M, Boothroyd D, Melsop K, et al. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation. 2004;110:1960-1966.
26. Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745-749.